Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LEXG-Lexicon Genetics -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (8)	10/1/2000 10:25:53 PM
From: Larry Liebman	Respond to of 254

In "Wired"(10/00), a discussion of lockups focusing on SABA and LEXG. Comparing LEXG to SABA, the author notes, "....Lexicon's directors and executives own a healthy 68 percent of its shares, and Baylor College of Medicine, which has close ties to the company, holds another 8 percent. The extra measure of loyalty can add up to dollars for investors when expiration day arrives". The article contrasts this with SABA, where 40%+ of shares eligible for release are in the hands of VC's.